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The Igk 39 Enhancer Influences
the Ratio of Igk versus Igl B Lymphocytes
James R. Gorman,*‡ Nienke van der Stoep,* al., 1980; reviewed by Chen et al., 1994). l-producing
cells often lack one or both Ck exons and 39 Ck se-Robert Monroe,* Michel Cogne,*§
quences owing to a V(D)J recombinational event involv-Laurie Davidson,*† and Frederick W. Alt*†‡
ing a recombination signal sequence (termed RSin mice)*Howard Hughes Medical Institute
located about 25 kb 39 of the Ck exon, suggesting aThe Children’s Hospital
potential role for this process in promoting l re-†Department of Genetics
arrangements (reviewed by Selsing and Daitch, 1995).Harvard Medical School
While rearrangement of the RS sequences themselves‡Center for Blood Research
is not required for l gene rearrangement (Chen et al.,Boston, Massachusetts 02115
1993b; Takeda et al., 1993; Zou et al., 1993), RS re-
arrangements might increase the generation of l pro-
ducers by other mechanisms, for example by deletionSummary
of elements within the k locus that inhibit l rearrange-
ment or by increasing the frequency of cells with non-We generated mice harboring germline mutations in
functional k genes (reviewed by Selsing and Daitch,which the enhancer element located 9 kb 39 of the
1995).immunoglobulin k light chain gene (39Ek) was replaced
Individual B cells express only one of their two alleliceither by a single loxP site (39EkD) or by a neomycin
H chain loci and one of their multiple L chain loci asresistance gene (39EkN). Mice homozygous for the
proteins that associate to form complete immunoglobu-39EkD mutation had substantially reduced numbers
lin (reviewed by Lansford et al., 1996). These allelic andof k-expressing B cells and increased numbers of
isotype (k versus l) exclusion processes are effectedl-expressing B cells accompanied by decreasedk ver-
by feedback mechanisms; for example, functional k Lsus l gene rearrangement. In these mutant mice, k
chain expression curtails further k gene rearrangementexpression was reduced in resting B cells, but was
and eliminates the opportunity for l gene rearrangementnormal in activated B cells. The homozygous 39EkN
to be initiated (Alt et al., 1980; Ritchie et al., 1984). Themutation resulted in a similar but more pronounced
ratio of k to l B cells (k/l ratio) in mice and humansphenotype. Both mutations acted in cis. These studies
(about 20/1 and 2/1, respectively) correlates with theshow that the 39Ek is critical for establishing thenormal
relative complexity of the Vk to Vl loci in those speciesk/l ratio, but is not absolutely essential for k gene
(reviewed by Lansford et al., 1996). As k gene re-rearrangement or, surprisingly, for normal k expres-
arrangement occurs preferentially to that of l genes insion in activated B cells. These studies also imply the
both species (Coleclough et al., 1981; Korsmeyer et al.,existence of additional regulatory elements that have
1982), the relative k/l ratios may be influenced by post-overlapping function with the 39Ek element. rearrangement mechanisms (Langman and Cohn, 1995).
All antigen receptor loci contain tissue-specific and
Introduction developmentally regulated enhancer elements (re-
viewed by Calame and Ghosh, 1995). The Igk locus has
Immunoglobulin (Ig) heavy (H) and light (L) chain variable two known enhancers: the intronic k enhancer (iEk),
region genes are assembled from multiple germline V, which lies between Jk and Ck (Emorine et al., 1983; Par-
(D), and J gene segments during early B cell differentia- slow and Granner, 1982; Picard and Schaffner, 1984),
tion (reviewed by Lansford et al., 1996; Okada and Alt, and the 39 k enhancer (39Ek), which lies about 9 kb down-
1995). The variable region gene segments in the single stream of Ck (Meyer and Neuberger, 1989). Most infor-
IgH chain locus and two IgL chain loci (k and l) are mation regarding potential functions of the k enhancers
assembled by a common V(D)J recombinase. Re- comes from assays of transfected and transgenic ex-
arrangement and expression of IgH chain variable region pression constructs. The iEk becomes active during the
genes usually precedes that of IgL chain genes (re- pre-B to B cell transition and may function in activating
viewed by Lansford et al., 1996). IgL chain gene re- k locus recombination and transcription (reviewed by
arrangement also appears ordered; it usually initiates Calame and Ghosh, 1995). The 39Ek is active at the B-cell
at the k locus, with l gene rearrangements occurring stage and beyond (Meyer and Neuberger, 1989; Park
predominantly in cells that have attempted and failed and Atchison, 1991; Pongubala and Atchison, 1991).
to assemble productive k genes (Alt et al., 1980; Cole- Studies of transgenic k loci suggested that 39Ek is re-
clough et al., 1981; Korsmeyer et al., 1982). quired for high level k expression in immunoglobulin-
The apparent ordering of L chain gene rearrangement secreting cells and for efficient exclusion of endogenous
might result from either a specific mechanism that ef- L chain gene rearrangement (Betz et al., 1994; Meyer et
fects “ordered” activation of the k and l loci or a “sto- al., 1990). Transfection studies further indicated that 39Ek
chastic” mechanism in which these loci are activated and iEk may function synergistically to promote tran-
simultaneously, with the probability of k gene re- scription in B cell lines (Fulton and Van Ness, 1993,
arrangement greatly exceeding that of l genes (Alt et 1994).
Enhancer elements promote rearrangement of linked
V, (D), and J segments in transfected and transgenic§Present address: Laboratory of Immunology, UFR Medicine, Uni-
versity of Limoges, Limoges, France. V(D)J recombination substrates (reviewed by Sleckman
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et al., 1996). Correspondingly, gene-targeted mutational Table 1. l1 B Lymphocytes in Heterozygous Mutant and Control
Miceaexperiments demonstrated that specific deletion of the
T cell receptor b (TCRb) enhancer blocked TCRb gene Mouse Genotype
rearrangement (Bories et al., 1996; Bouvier et al., 1996)
Cell Type 1/1 39Ek1/N 39Ek1/Dand that specific deletion of the intronic IgH enhancer
Peripheral blood lymphocytesb, e(Em) partially inhibited IgH gene rearrangement (Serwe
Percent l1 B cellsc 3.6 6 1 6.7 6 1.5* 6.9 6 0.8*and Sablitzky, 1993). Notably, replacement of Em with a
Splenic lymphocytesdneomycin resistance (neor) gene led to more complete
Percent l1 B cellsc 5.1 6 1 8.4 6 0.3 10.0 6 2.6inhibition (Chen et al., 1993a), suggesting that the neor
a Peripheral blood lymphocytes and splenocytes were isolated fromgene may inhibit additional IgH elements that promote
mice 4–8 weeks old, stained, and analyzed by flow cytometry asrearrangement in the absence of Em. In this context,
described in Experimental Procedures.Mice included both germlinereplacement of iEk with a neor gene also blocked Igk mice, derived as described in Experimental Procedures, and chime-
rearrangement (Takeda et al., 1993), potentially owing ric mice derived by RAG-deficient blastocyst complementation, as
to deletion of iEk, inhibition of other elements (e.g., 39Ek), previously described (Chen et al., 1993c). In all cases, results with
or both. In contrast with these findings, a recent chimeric mice were identical to results with germline mice.
b We analyzed 8–9 mice of each genotype.transgenic study concluded that 39Ek works as a nega-
c Percentage of l1 B cells was defined as percent IgM1, l1/percenttive regulator of VkJk rearrangement in T cells and pro-
IgM1 or as percent l1, B2201/percent B2201.genitor B cells (Hiramatsu et al., 1995).
d We analyzed 2–4 mice of each genotype.
In the current study, we have employed a gene-tar- e Mutant values that differed significantly from the 1/1 strain are
geted mutational approach to test directly the require- indicated by an asterisk. In mutant spleen, too few mice were avail-
ment for the 39Ek in rearrangement and expression of able to analyze conclusively the statistical significance of the results.
the Igk locus.
percentage of l B cells represented an increased num-
Results ber of l B cells. These data indicate an apparent gene
dosage effect of the 39Ek deletion on accumulation of lTargeted Mutation of the 39Ek Element B cells, similar in magnitude to that previously observed
We have used the Cre–loxP strategy (Gu et al., 1993) to in the context of k locus mutations that completely elimi-
inactivate the 39Ek region specifically. A targeting vector nate production of k B cells (Chen et al., 1993b; Zou et
was constructed in which the entire 808 bp 39Ek region al., 1993).
(Meyer and Neuberger, 1989) was replaced with a PGK– In young 39EkD/D mice, the total number of splenic B
neor gene flanked by loxP sites (Figure 1a, 1). Gene cells was reduced, on average, by 2-fold (Table 2). This
targeting (Mansour et al., 1988) was used to obtain sev- reduction resulted from a 3-fold decrease in the number
eral independent embryonic stem (ES) cell clones in of k-producing cells. In contrast, the number of l-pro-
which one copy of the 39Ek element was replaced by the ducing B cells was increased by about 3-fold. These
loxP–neor–loxP cassette (Figure 1a, 3). Two independent changes resulted in a k/l ratio of approximately 2/1 in
heterozygous mutant (39Ek1/N) ES cell clones were em- 39EkD/D mice as opposed to 20/1 in normal mice. Theployed to generate lines of mice carrying this mutation 39EkN/N mice had even more dramatic changes of a simi-in their germline; heterozygous mutants were then bred lar nature, with a resulting k/l ratio of substantially
to obtain homozygous mutants (Figure 1b; only results less than 1/1 (Table 2; Figure 2). To address the question
with the 39Ek1/1 and 39EkN/N genotypes are shown). To of whether the altered splenic B cell k/l ratio arose in
obtain in vivo Cre–loxP-mediated excision of the neor the bone marrow or in the periphery, we similarly as-
gene, we bred homozygous 39EkN/N females with male sayed the size and content of the precursor (B220low/
mice carrying a transgene (EIIa–CreTG) in which the cre IgM2), newly generated (B220low/IgM1), and recirculating
recombinase is expressed under the control of the ade- (B220high/IgM1) bone marrow B lineage cell compart-
novirus EIIa promoter (Lakso et al., 1996). The EIIa pro- ments of a subset of the mice (Figure 2). In both types
moter targets expression of the Cre protein to the early of homozygous 39Ek mutant mice, the ratio of newly
mouse embryo, where it catalyzes Cre-mediated exci- generated to precursor B cells was significantly de-
sion of the neor gene (Figure 1b). This approach was creased (Table 2), suggesting that the homozygous 39Ekused to generate progeny that are heterozygous for the mutations may decrease the efficiency of B cell genera-
excision mutation (39Ek1/D) in their germline (Lakso et al., tion in the bone marrow. Furthermore, the B cell k/l
1996); these were interbred to yield homozygous 39Ek ratios in the newly generated and recirculating compart-
excision mutant mice (Figure 1b, 39EkD/D). ments of the bone marrow of both mutant mouse strains
were substantially elevated compared with normal mice
(Table 2; Figure 2), indicating that the altered k/l ratioMice Lacking 39Ek Show a Decreased k/l Ratio
Mice heterozygous for the deletion and replacement in theperiphery of mutant mice is establishedto a signifi-
cant extent during the generation of B cells in the bonemutations had a 2-fold increase in the percentage of l
B cells in peripheral blood and spleen compared with marrow. However, the more substantial alteration in the
k/l ratio in the spleens versus bone marrow of mutanttheir wild-type, strain-matched littermates (Table 1; data
not shown). However, neither type of heterozygous mu- mice (Table 2) indicates that additional processes influ-
ence the k/l ratio subsequent to generation of B cellstant had a significantly decreased number of splenic
B cells (data not shown), indicating that the increased in the bone marrow.
39k Enhancer-Deleted Mice
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Figure 1. Targeted Mutations of the 39Ek Element
(a) Targeting strategy. (1) Targeting construct. Closed triangles flanking the neor gene represent loxP sites in direct repeat orientation. (2)
Endogenous locus. Closed rectangles below represent probes used in the various studies. (3) Targeted locus with the loxP–neor–loxP cassette
replacing the region between the XhoI site and the EcoRI site of the endogenous locus. (4) Targeted locus after in vivo Cre–loxP-mediated
excision of the neor gene. Restriction enzyme sites are represented as follows: B, BamHI; Xh, XhoI; R, EcoRI; H, HindIII.
(b) Southern blotting of tail DNA. Tail DNA digested with BamHI was probed with probe C. Data are presented for ES cells, for germline mice
carrying the loxP–neor–loxP cassette (neo g.l.), and for the F1 and F2 offspring of matings between neo germline and Cre transgenic mice.
Wild-type, Neo, and DNeo bands, and MW markers, are as indicated. Predicted sizes of the bands seen in BamHI-digested DNA probed with
probe C are: wild type, 6 kb; Neo, 3.5 kb; DNeo, 2 kb.
The 39Ek Mutation Is cis-Acting on the k Locus ES cells into recombination-activating gene 2 (RAG-2)-
deficient blastocysts (RAG-2-deficient blastocyst com-To determine whether the 39Ek mutations lead to a cis-
acting effect on expression or rearrangement (or both) plementation; Chen et al., 1993c). 39Ek1/N kidney DNA
contained equal levels of the unrearranged wild-typeof the IgL k locus, we employed Southern blotting meth-
ods to assay for retention of unrearranged normal and and mutant k alleles, while 39Ek1/D chimera kidney DNA
contained a decreased level of the unrearranged mutantmutant k loci in DNA of lipopolysaccharide (LPS)-acti-
vated splenic B cells. Mice were derived by germline allele owing to incomplete contribution of the ES cells
to this nonlymphoid tissue (Figure 3). In contrast, LPS-transmission (39Ek1/N) or by injection of 39Ek1/D mutant
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Table 2. Lymphocyte Populations in Mutant and Control Micea, o
Mouse Genotype
Cell Type 1/1 39EkN/N 39EkD/D
Splenic B cells, young mice j
Number of nucleated cellsa (3 106) 75 6 18 48 6 15† 45 6 7†
Percent B cellsb 47 6 11 31 6 1† 37 6 4†
Number of B cellsc (3 106) 38 6 7 16 6 7* 18 6 4*
Splenic B cells, adult micek
Number of nucleated cellsa (3 106) 101 6 50 49 6 22† 61 6 37 †
Percent B cellsb 53 6 6 46 6 5* 41 6 7*
Number of B cellsc (3 106) 47 6 22 16 6 5† 25 6 9†
Spleen, k and l cellsl
Percent k1 B cellsd 94 6 3 18 6 7* 61 6 12*
Number of k1 B cells (3 106) 42 6 19 3 6 2* 15 6 7*
Percent l1 B cellse 5 6 4 78 6 7* 35 6 13*
Number of l1 B cells (3 106) 2 6 1 11 6 5* 6 6 3†
Bone marrowm
Number of nucleated cells (3 106) 26 6 7 19 6 7† 23 6 6†
Percent lymphocytes 33 6 8 38 6 5† 34 6 7†
Percent B cell precursorsf 38 6 11 43 6 7† 42 6 8†
Percent newly generated B cellsg 14 6 4 8 6 2† 8 6 5†
Percent recirculating B cellsh 14 6 6 7 6 4† 9 6 5†
Percent new/percent precursor B cellsi 0.39 6 0.14 0.18 6 0.04* 0.20 6 0.10*
Bone marrow: newly generated compartmentn
Percent k1 Cellsd 96 6 2 46 6 7* 82 6 4*
Number of k1 Cells (3 105) 12 6 2 3 6 0.4* 5 6 0.3*
Percent l1 Cellse 4 6 2 55 6 7* 18 6 4*
Number of l1 B Cells (3 105) 0.5 6 0.2 3 6 0.4* 1 6 0.2†
Ratio of number of new k/number of new l1 29 6 13 0.9 6 2* 5 6 1*
a Splenocytes and bone marrow cells were isolated as described in Experimental Procedures. Young mice were 4–6 weeks old; adult mice
were 9–24 weeks old, except one adult N/N mouse was 10 months old. Spleen cells were recovered from an entire spleen or nucleated bone
marrow cells from the bone marrow of two femurs. All percentages represent percentages of cells in the lymphocyte gate, as defined by
forward scatter and side scatter (Forster et al., 1989).
b Splenic B cells were defined as percent IgM1 cells or as (percent k1 cells plus percent l1 cells).
c Product of (number of nucleated cells) 3 (percent of B cells).
d k1 B cells were defined as percent IgM1, k1/percent IgM1.
e l1 B cells were defined as percent IgM1, l1/percent IgM1.
f B cell precursors were defined as CD45R/B220low, IgM2.
g Newly generated B cells were defined as CD45R/B220low, IgM1.
h Recirculating B cells were defined as CD45R/B220high.
i New B cells are as defined in (g). Precursor B cells are as defined in (f).
j Number of nucleated cells, n 5 2–5. Percent and number of B cells, n 5 4 1/1, 2 N/N, and 4 D/D mice.
k Number of nucleated cells, n 5 5–7. Percent and number of B cells, n 5 6 1/1, 3 N/N, and 6 D/D mice.
l For percent k1 or percent l1 cells, n 5 11 1/1, 6 N/N, and 13 D/D mice. For number of k1 or l1 cells, n 5 7 1/1, 5 N/N, and 8 D/D mice.
No significant differences were noted between young and old mice, so all results were pooled.
m For number of nucleated cells and percent lymphocytes, n 5 5–12 mice. For compartment analysis, n 5 2–5 mice. Nucleated bone marrow
cells were recovered from two femurs. All percentages represent percentages of cells in the lymphocyte gate, as defined by forward scatter
and side scatter. No significant differences were noted between young and old mice, so all results were pooled.
n n 5 3 1/1, 2 N/N, and 4 D/D mice. The number of newly generated cells was calculated as [(number of nucleated cells) 3 (percent
lymphocytes) 3 (percent newly generated lymphocytes) 3 (percent k1 or percent l1)]. 1/1 and D/D mice were young mice; N/N mice were
adult mice.
o Results tested for statistically significant difference as described in Experimental Procedures. * Mutant strain values that differed significantly
from the 1/1 strain. † Mutant strain values that did not differ significantly from the 1/1 strain value.
activated B cells from the 39Ek1/D/RAG-22/2 chimeras (all any case, the preferential retention of the mutant allele
in these experiments clearly shows that both the 39Ekof which are ES cell derived) or from the 39Ek1/N mice
retained with high preference the mutant versus the insertion and deletion mutations exert effects on the
rearrangement status of the k locus through a cis-actingwild-type allele in germline configuration (Figure 3). Pref-
erential retention of a mutant versus wild-type unre- mechanism.
arranged allele in activated mutant B cells is consistent
either with a specific block in rearrangement of the mu- Absence of 39Ek Decreases k Locus
Rearrangement in l B Cellstant allele or with an effect on expression of the re-
arranged mutant locus sufficient to impair feedback inhi- To elucidate further the mechanism of increased l cell
generation in homozygous 39Ek mutants, we assayedbition of rearrangement or to promote preferential
accumulation of cells expressing the wild-type allele. In purified l B cells for retention of the germline EcoRI–
39k Enhancer-Deleted Mice
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Figure 2. Flow Cytometric Analysis of Sur-
face Immunoglobulin Expression in Spleen
and Bone Marrow
Analysis of splenocytes and bone marrow
cells of 1-month-old mice stained with FITC-,
PE-, and biotin- or CyC-conjugated antibod-
ies to the markers indicated. Percentages are
calculated as a percentage of the total IgM1
cells in each sample. The two regions in the
IgM versus B220 stains represent B220low and
B220high cells. All samples are lymphocyte
gated by forward scatter and side scatter.
N/N bone marrow only was from an adult N/N
mouse, as defined in the legend to Table 2.
BamHI restriction fragment spanning the Jk region and hybridomas (Table 4). We also assessed the extent of
RS rearrangement by assaying for retention of the 39for retention of the germline EcoRI–BamHI restriction
fragment spanning the RS region (Figure 4; Table 3). As RS germline band. In 39Ek1/1 l B cells, the germline RS
region was 45% retained, indicating that more than halfobserved previously (Coleclough et al., 1981; Takeda et
al., 1993), the germline Jk region was almost completely of k loci in l cells had undergone an RS rearrangement.
The 39EkD/D and 39EkN/N l B cells showed increased, butdeleted in the 39Ek1/1 l B cells (5%–6% retained). In
contrast, the germline Jk region was approximately 25% not complete, retention of germline RS sequences (61%
and 89% on average, respectively; Figure 4; Table 3).retained in 39EkD/D l B cells and 64% retained in 39EkN/N
l B cells (Table 3). In agreement with the sorting data, Together, these data indicate that the 39Ek element is
required for normal levels of both Jk and RS rearrange-l hybridomas from 39EkD/D mice also had a substantially
increased percentage of retained germline Jk alleles ment in l-producing cells, but that this element is not
absolutely required for either type of rearrangement.compared with that observed previously in wild-type l
Immunity
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Table 3. Retention of Jk and RS Germline in Sorted l B Cellsa
HdIII digest (%) 1/1 N/N D/D
Jk germlineb 5 62 15
RS germlinec ND 73 55
RI/Bam digest (%) 1/1 N/N D/D
Jk germline 6 67 32
RS germline 45 105 67
Average retention (%) 1/1 N/N D/D
Jk germline 6 65 24
RS germline 45 89 61
a Quantification was performed as described in the legend to Fig-
Figure 3. Southern Blot Analysis of Retention of Germline k Loci in
ure 7.Splenic B Cells
b All figures represent the average of values obtained for each ge-
DNA isolated from 5 day LPS-stimulated splenocytes and from kid- notype.
ney was digested with EcoRI and used to prepare Southern blots, c ND, not determined.
which were then probed with probe A (see Figure 1a, 1). 1/1 and
1/N mice were littermates obtained by germline transmission of the
N allele. 1/D mice were obtained by injection of 1/D ES cells into
RAG blastocysts. performed these analyses with anti-IgM antibodies, as
would be expected if the amount of IgL chain produced
limits the amount of immunoglobulin that can be ex-
pressed on the surface (data not shown). These dataThe 39Ek Regulates Surface k Expression
in Resting B Cells indicate that the 39Ek is required for normal expression
levels of the Igk chain on the cell surface in unstimulatedTo assess the role of 39Ek in controlling expression of
the k protein, surface k expression levels were quantified B cells. In this context, we also tested levels of k expres-
sion on mutant and normal B cells after 4 days of LPSby comparison of fluorescence intensity (Figure 5; data
not shown). With several different anti-k antibodies, stimulation and found both to express similar levels of
surface k (Figure 5B). However, in this case, surfacesplenic B cells (unmanipulated) from D/D or N/N mice
were seen to have a 2- to 3-fold decrease in k fluores- immunoglobulin on wild-type activated B cells was
down-regulated compared with that on unactivatedcence intensity compared with those of wild type (Fig-
ure 5A). We observed a similar decrease on mutant cells, as expected given that activation leads to produc-
tion of the secreted form of IgM (reviewed by Calame,k-expressing, but not on l-expressing, B cells when we
Figure 4. Southern Blot Analysis of Jk and RS Rearrangement in Sorted l-Expressing B Cells
(A) Schematic diagram of the Igk locus. Restriction enzyme site abbreviations are as in Figure 1; Sa, Sau3A.
(B) The amount of EcoRI–BamHI-digested DNA was standardized by probing with c-myb probe. To calculate the percentage of germline Jk,
we calculated the Jk/c-myb ratio and set the ratio for kidney equal to 100% germline. A ratio was then calculated for each sample as follows:
(ratio in sample/ratio in kidney). These ratios were converted to percentages by multiplying by 100 and are presented as percentages of the
germline seen in kidney.
(C) The percentage of germline RS was calculated in a similar fashion using the RS/c-myb ratio. Similar results were obtained for germline
Jk and RS with independent blots using HdIII-digested DNA and c-myc or c-myb probes for standardization (Table 3). The 129/Sv allele (from
which the 1/1 l cells were sorted) contains a polymorphism at the RS locus (data not shown), resulting in a germline allele about 2 kb larger
than seen in N/N and D/D cells.
39k Enhancer-Deleted Mice
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Table 4. Analysis of Rearrangement in k and l Hybridomasa
Retention of Jk germline in l hybridomasb 1/1 D/D
Percent with Jk germlinec 8 (1 of 12) 45 (10 of 22)
Number of cells with Jk germline with
no RS or Jk rearrangementsd 0 of 1 6 of 10
Possible range of retained
Jk germline allelese 4% (1 of 24) 23%–36% (10 of 44 to 16 of 44)
Retention of Jk germline in k hybridomas 1/1 D/D
Percent with Jk germline 58 (14 of 24) 44 (12 of 27)
a DNA was prepared from hybridomas grown and typed as described in Experimental Procedures.
b We digested 10 mg of each hybridoma DNA sample with HdIII and analyzed it by Southern blotting analysis with probe A. This probe detects
no germline band in the fusion partner and a 2.8 kb Jk germline band in the kidney or in a fused B cell that has retained an unrearranged k
locus. Jk germline band in N/N hybridomas was analyzed by a PCR assay that specifically detected the knockout germline band, as described
in Experimental Procedures.
c This value for 1/1 l hybridomas was taken from published results (Coleclough et al., 1981; Nadel et al., 1990).
d Each hybridoma with a Jk germline band was analyzed for the presence of rearranged Jk or a rearranged RS band (or both), as described
in Experimental Procedures. Hybridomas with a Jk germline band and a detectable rearranged Jk or RS band were counted as having only
one Jk germline band. The remaining hybridomas, showing one germline Jk band, could either have two germline Jk alleles or could have one
germline Jk allele and a rearranged Jk band that cannot be detected owing to chromosome loss or to comigration with one of the hybridoma
germline bands, as has been seen in previous analyses (Coleclough et al., 1981; Nadel et al., 1990). Hybridomas with a Jk germline band and
no detectable rearranged Jk or RS band were therefore counted as having one (lower limit of range) or two (upper limit of range) Jk germline
bands.
e The minimum was calculated assuming that all hybridomas with one or two Jk germline bands have only one Jk germline band. The maximum
was calculated assuming that all hybridomas with one or two Jk germline bands have two Jk germline bands.
1985). Therefore, to compare k expression levels in se- assayed by Northern blot analysis of RNA samples from
LPS-stimulated splenocytes and normalized to accountcreting cells directly, we employed RNA expression
analyses as described below. for the total amount of B cell RNA in each lane and for
the relative number of k B cells in each culture (Figure
6). Stimulated B cells from 39EkD/D mice showed a levelNormal k Expression by D/D but Not N/N
Antibody-Secreting B Cells
To determine whether absence of the 39Ek would dra-
matically inhibit k expression levels in antibody-secret-
ing B cells, as it had in transgenic models (Betz et al.,
1994; Meyer et al., 1990), Ck-hybridizing RNA levels were
Figure 6. Northern Blot Analysis of Ck Transcripts
Splenic cells were first cultured with 20 mg/ml bacterial LPS for 4
days, which results in cultures containing greater then 96% B2201
cells (data not shown). Total RNA was prepared from splenocytes
stimulated for 4 days, blotted, and probed as described in Experi-
mental Procedures. The blot was sequentially probed with probe B
(a Ck probe) and with a 0.9 kb EcoRI fragment encoding the cDNA
for the B lineage–specific message of the mb-1 gene. The ratio of
Ck to mb-1 signal was calculated by densitometry to standardize
the amount of B cell RNA loaded in each lane. The percentage of
Figure 5. Effect of 39Ek on Surface k Expression k-expressing B cells in each culture, as determined by FACS analy-
sis, is presented to allow an approximate comparison of the number(A) Freshly isolated splenocytes were stained with FITC- and PE-
conjugated antibodies to the markers indicated. Surface k1 cells of k loci present. Ck signal per cell was calculated as the [(Ck/mb-1)/
percent k1 cells] ratio in 1/1 cells divided by the same ratio forwere gated, and histograms of k fluorescence intensity were dis-
played in an overlaid fashion for 1/1 and D/D splenocytes. 1/1, N/N, and D/D samples, respectively. These final ratios were
converted to percentages by multiplying by 100 and are presented(B) Normal and D/D splenocytes stimulated for 4 days with 20 mg/
ml bacterial LPS were stained and displayed as in (A). as percentages of the per cell Ck message in 1/1 cells.
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of heterozygous mutants. Therefore, the 39Ek is indeed
a cis-acting regulatory element of the Igk locus.
39Ek Regulates the k/l Ratio and Ordered
Light Chain Gene Rearrangement
The l B cells from 39EkD/D mice have increased retention
of germline Jk sequences and germline RS, suggesting
that the 39Ek is involved in processes that lead to prefer-
ential rearrangement of the k versus l locus, either by
promoting k rearrangements or by inhibiting l re-
Figure 7. Analysis of k Chain inSera and in Hybridoma Supernatants arrangements (or both) in rate or time. Decreased k
(A) Serum k chain in sera from 10- to 16-week-old mice. The first rearrangement could result in decreased accumulation
1/1 column is strain-matched littermates of N/N mice; the second of k B cells and increased accumulation of l B cells
1/1 column is strain-matched littermates of D/D mice.
owing to decreased feedback inhibition by IgM(k). Po-(B) Serum k chain production by k1 hybridomas. 1/1 hybridomas
tential mechanisms by which the 39Ek might directly in-were derived from 1/1 littermates of N/N mice.
hibit l rearrangement would include competition for lim-
ited recombinational machinery or for limited nuclear
of Ck-hybridizing RNA expression per cell roughly similar recombination sites. In addition, the requirement for the
to that of normal B cells (Figure 6). In contrast, the Ck- 39Ek to generate normal expression levels of surface
hybridizing RNA level in 39EkN/N B cells was reduced immunoglobulin on resting B cells also could lead to
3-fold. Production of k protein was also assayed by two decreased numbers of newly generated and peripheral
different approaches (Figure 7). First, k protein levels k B cells in 39EkD/D mice via postrearrangement selection
were assayed by enzyme-linked immunosorbent assay or feedback mechanisms. Finally, an increase in l B cell
(ELISA) in serum from littermates of each genotype (Fig- generation in 39EkD/D mice could result if the decreased
ure 7A). Second, k protein production by hybridomas number of functional k-expressing cells in mutant bone
from mice of each genotype was compared (Figure 7B). marrow led to increased availability of stromal sites for
As assessed by both assays, B cells from 39EkD/D mice positive selection of l cells. In all of these scenarios,
had approximately normal levels of k protein secretion, which are not mutually exclusive, deletion of the 39Ek
while those from 39EkN/N mice appeared to have slightly element via RS rearrangements could promote accumu-
decreased levels. In summary, these data indicate that lation of l cells.
activated and antibody-secreting B cells lacking the 39Ek
element can produce normal levels of Ck transcripts and
k protein, but insertion of a neor gene partially inhibits The Role of the 39Ek in Regulating
k Locus Expressionthis process.
Absence of the 39Ek decreases k expression to about
one third its normal level in resting B cells, indicatingDiscussion
that the 39Ek element functions to maintain baseline ex-
pression at this stage. However, k expression levels arecis-Acting Insertion and Replacement Mutations
of the 39Ek normal in activated B cells of 39EkD/D mice (Figures 5, 6,
and 7). This finding is surprising, since previousWe have compared the effects of two germline muta-
tions of the 39Ek. In one mutant mouse strain, the 39Ek transgenic studies implicated the 39Ek element as critical
for high level expression of rearranged k constructs con-was replaced with an inserted neor gene; in the other,
the inserted neor gene was deleted to leave only a short, taining the iEk element (Betz et al., 1994; Blasquez et
al., 1992, 1989; Carmack et al., 1991; Rusconi andpresumably inert, loxP sequence. Both mutations led to
a major alteration of the normal k/l ratio, which resulted Kohler, 1985; Storb et al., 1992, 1984). However, the
results could be reconciled if there is an additional en-both from decreased accumulation of k-bearing cells
and from increased accumulation of l-bearing cells. In dogenous element, absent from the transgenic con-
structs, that cooperates with iEk to drive high level en-addition, both types of homozygous mutants had an
altered ratio of newly generated to precursor B cells dogenous k locus expression in the absence of 39Ek. In
this context, B cell activation and terminal differentiationsimilar to that observed in mutant mice in which the k
locus was completely inactivated by targeted mutation may stimulate multiple, distinct signaling pathways,
some acting through the 39Ek and some through the iEk,(Chen et al., 1993b; Takeda et al., 1993; Zou et al., 1993).
By analogy, this latter phenotype may reflect a major any one of which is sufficient to stimulate high level k
expression. LPS stimulation is believed to activate iEkdecrease in the generation of k B cells only partially
compensated by increased generation of l B cells. While primarily by mobilization of NF-kB (Lenardo et al., 1987);
correspondingly, this pathway may allow iEk to compen-the homozygous deletion mutation had significant nega-
tive effects both on expression of variable region genes sate for the absence of 39Ek in activated B cells. The
132 bp 39Ek core enhancer does not contain NF-kB sitesat the Jk locus and on assembly of k versus l joints, the
homozygous insertion mutation had even more dramatic (Pongubala and Atchison, 1991), but does bind the B
cell–specific ets family member Pu.1 (Pongubala et al.,effects on these processes. Both mutations acted in cis
on the associated k locus in that they led to preferential 1992). This is consistent with the possibility that the 39Ek
may be activated by different signaling pathways thanretention of the targeted germline allele in splenic B cells
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iEk, of which one may be required for normal k expres- Through appropriate immunizations, we should be able
to address this issue directly in the 39EkD/D mice. Analysession in resting B cells.
of transgenic k rearrangement constructs have further
suggested that sequences in the 39Ek region may inhibit
Possible Functions of the k Enhancers k light chain rearrangement at the pro-B stage and in T
In parallel studies, potential functions of the iEk and lineage cells (Hiramatsu et al., 1995). In this regard, our
its flanking matrix attachment region (MAR) sequences 39Ek deletion eliminates both the core 39Ek (Meyer and
have been analyzed by the Cre–loxP mutagenesis ap- Neuberger, 1989) and the putative suppressive se-
proach (Xu et al., 1996). In contrast with the 39Ek, the iEk/ quences flanking the core (Park and Atchison, 1991).
MAR was dispensable for normal k protein expression in Preliminary results do not show a substantial level of k
resting B cells. However, neither enhancer was required gene rearrangement in T cells of 39EkD/D mice (N. v. d. S.,
for normal k expression in activated B cells, at least J. R. G., and F. W. A., unpublished data), although more
when the other was present (Xu et al., 1996). Like the detailed analyses will be necessary to assay for lower
39Ek, the iEk/MAR region is required for maintenance of level effects of this mutation.
the normal k/l ratio. However, compared with deletion
of 39Ek, deletion of iEk/MAR resulted in a more pro- Effects of the Inserted neor Gene
nounced, but still incomplete, inhibition of Jk and RS Recent studies have demonstrated inhibitory effects of
rearrangement, indicating that iEk/MAR also is not es- neor genes inserted into the b-globin locus (Fiering et al.,
sential for this process. Thus, the 39Ek and iEk/MAR ele- 1995, 1993; Kim et al., 1992), adjacent to an Em elementments may work together, potentially with additional inserted into the TCRb locus (Bories et al., 1996), and
elements, to promote the full rearrangement potential in place of the iEk element (Xu et al., 1996). These studies,of the k locus. One such additional element may be the together with ours, emphasize the importance of delet-
KI–KII sequence upstream of Jk1, which a recent gene- ing expressed marker genes in mutational analyses
targeted deletion study has implicated in regulation of aimed at evaluating regulatory element functions. Our
k locus rearrangement (Ferradini et al., 1996). However, study demonstrates that such inserted marker gene ef-
the effect of KI–KII deletion was distinct from that of the fects are cis-acting, an assumption in other studies.
39Ek and iEk/MAR deletions, as mice homozygous for The latter finding allows us to conclude further that the
the former had normal B cell numbers and normal k/l inhibitory effects of such insertions can be mediated
ratios (Ferradini et al., 1996). over substantial distances, as the 39Ek mutation is about
The reason that the k locus harbors two different tran- 11 kb downstream of the Jk region where k variablescriptional enhancers is still speculative. The current region genes are assembled and transcribed.
data suggest that the iEk/MAR and 39Ek elements have There are several mechanisms by which an inserted
partially overlapping activities, with each playing a rela- neor gene may exert inhibitory effects (Chen et al.,1993a;
tively more important role in particular functions. In this Cogne et al., 1994; Fiering et al., 1995; Kim et al., 1992;
regard, the iEk/MAR region appears to influence the k/l Takeda et al., 1993; Xu et al., 1996). We suspect that
ratio primarily through effects on rearrangement, while our replacement mutation may (in addition to deleting
the influence of the 39Ek on this ratio likely results from 39Ek) interfere with activities of additional control ele-effects on both rearrangement and expression. It will, ments in the locus, including the iEk or other unknown
therefore, be of interest to determine the relative effects elements, and may as a result lead to more complete
of the iEk/MAR versus the 39Ek mutation on germline negative effects on transcription and rearrangement
k transcription, which occurs prior to rearrangement than deletion of individual elements. A similar interpreta-
(Schlissel and Baltimore, 1989; Van Ness et al., 1981). tion was offered in an analogous study that found that
The IgH locus also contains several widely spaced en- replacement of the 59HS2 site (a putative transcriptional
hancer elements, including Em and the 39 IgH enhancer regulatory element) of the b-globin locus with an in-
(39EH), which lies nearly 200 kb downstream. It remains serted neor gene inhibited b-globin transcription, but
to be determined whether the IgH locus enhancers work that deletion of the neor gene restored transcription (Fie-
together for some processes. However, Em appears to ring et al., 1995). With respect to defining all elements
be important for V(D)J recombination, while the 39EH (or involved in regulating the k locus, it will be of interest
associated elements) is essential for regulating germline to determine whether simultaneous inactivation of the
transcription of, and switching to, downstream CH genes 39Ek and iEk completely abolishes k rearrangement, ex-(Cogne et al., 1994). The TCRb locus, unlike the IgH pression, or both.
and IgL k loci, does not undergo genetic modifications
subsequent to rearrangement; notably, deletion of the
Experimental Proceduressingle defined TCRb enhancer inactivates rearrange-
ment of this locus (Bories et al., 1996; Bouvier et al., Construction of Targeting Vector
1996). The plasmid pRH43 (Abremski et al., 1983), containing two loxP
sites flanking a kanamycin resistance gene, was digested withThe 39Ek may also be important, directly or indirectly,
EcoRI, blunted with Klenow, and religated with a NotI linker. Thefor processes besides rearrangement and transcription
HdIII–BamHI kanamycin resistance gene–containing fragment of theof the k locus. Previous transgenic studies implicated
resulting vector was then replaced by a 157 bp fragment of pBR322the 39Ek as necessary for somatic mutation of k along with a PGK–neor (phosphoglycerate kinase promoter–
transgenes (Betz et al., 1994); however, these studies neomycin phosphotransferase) gene cassette. The resulting vector
didnot establish whether39Ek plays a role in the mutation contained a loxP–neor–loxP cassette. A PGK–TK (thymidine kinase)
gene cassette (Tybulewicz et al., 1991) was then cloned as an XhoI–process distinct from its requirement for expression.
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SalI fragment into the 39 XhoI site, thereby introducing a PGK–TK (RA3-6B2). The following Southern Biotechnology Associates goat
anti-mouse antibodies wereused: PE-conjugated anti–l chain (cata-cassette outside of the loxP sites and reconstituting the XhoI site
59 of the PGK–TK cassette. The NotI site of the vector was then log number 1065-09) and FITC-conjugated anti–k chain (catalog
number 1055-02).converted to a SalI site, and the 13.5 kb SalI–XhoI fragment of
pRx2-7 (Muller et al., 1990), containing the 13.5kb EcoRI–XhoI geno- Spleen cells were cultured in complete RPMI, supplemented with
10% fetal bovine serum (Sigma), penicillin–streptomycin, glutamine,mic k locus fragment, was cloned into this SalI site. Finally, a 2.5
kb fragment of pRx-RI (Muller et al., 1990), containing a 2.5 kb and 50 mM b-mercaptoethanol, plus 20 mg/ml bacterial LPS for 3–5
days. For purification of l cells, single cell suspensions from spleensEcoRI–BamHI genomic fragment, was cloned into the XhoI site of
the vector to make the targeting vector. of one (N/N or D/D) or several pooled (1/1) mice were stained with
biotin-conjugated anti-l monoclonal antibody R26-46 (Pharmingen)
and positively selected with streptavidin-conjugated beads (Dynal)Gene Targeting in ES Cells and Generation of Mutant Mice
according to the instructions of the manufacturer. l-enriched spleenE14.1 ES cells were transfected with 25 mg of SalI-linearized vector
cells were cultured in LPS-containing complete RPMI medium forDNA and then selected with G418 and ganciclovir as described
3–4 days and then restained with PE-conjugated goat anti–mousepreviously (Kuhn et al., 1991). Homologous recombinants were iden-
l (Southern Biotechnology Associates) and with either FITC-conju-tified by Southern blotting of HdIII-digested DNA probed with probe
gated B220 (Pharmingen) or FITC-conjugated goat anti–mouse kD (the 1 kb XbaI fragment of pRxRI). Two clones (71 and 102) were
antibodies (Southern Biotechnology Associates). l-expressing cellssubcloned, screened again by Southern blot to identify subclones
were then sorted on a FACSVantage (Becton–Dickinson), reana-carrying the knockout allele (subclones 71.7 and 102.4), and injected
lyzed, and found to be 95%–99% l positive. Genomic DNA wasinto C57/Black6 blastocysts as described previously (Shinkai et al.,
prepared as described above, and 10 mg was digested and analyzed1992). Resultant male chimeras were assessed by coat color and
by Southern blot analysis with appropriate probes.bred with wild-type C57/Black6 females to test for germline trans-
mission. Germline-transmitting offspring, identified by coat color,
Hybridoma Generation and Analysiswere assayed by Southern blot analysis of tail DNA; offspring car-
Activated B cells from 5 day LPS cultures were fused to P3-X63-rying the N allele were interbred, yielding 1/1, 1/N, and N/N off-
Ag8.653, a non-k-chain-producing fusion partner (Kearney et al.,spring in Mendelian ratios.
1979) by standard techniques. Supernatant from clones growing inFemales of the N/N genotype were bred with homozygous EIIa–
HAT-supplemented RPMI, 15% fetal bovine serum was obtained atcre transgenic mice (Lakso et al., 1996) to obtain F1 offspring.
days 7–9 of HAT selection and screened for k or l production byDeletion of the neor gene was assayed by Southern blotting and/or
ELISA (see below). Positive wells in series with less than 1 in 4polymerase chain reaction (PCR) of tail DNA. F1 mice that had
positive wells were either expanded and used for extraction of geno-completely excised the neor gene in the tail were interbred; F2
mic DNA or subcloned by limiting dilution, expanded, and then usedmice were assayed for excision of the neor gene and for the pres-
for extraction of genomic DNA. Genomic DNA (10–20 mg) was di-ence or absence of the cre transgene by PCR of tail DNA. Primers
gested by EcoRI or HindIII, which were blotted as described above,used were as follows: 39Flank, 59-actaacatttgacaggtggatgc-39;
and hybridized to appropriate probes.loxP, 59-ggccgctaattccgatcatattc-39; neor, 59-ccttcttgacgagttcttctg
agg-39. PCR reactions were carried out as described previously
(Kogan et al., 1987) and included 200 ng of tail DNA and 2.5 U ELISA Analysis
of AmpliTaq polymerase (Perkin Elmer). PCR conditions were as Supernatants from hybridoma cultures and serum from 10- to 20-
follows: 948C for 2 min and then 45 cycles of 948C for 30 s, 508C week-old mice were analyzed for the presence of Igk or Igl light
for 45 s, 658Cfor 1 min 30 s. Products were separated by electropho- chains by ELISA (Burstein et al., 1991). To analyze hybridoma k
resis on a 1.5% agarose gel and visualized by staining with ethidium chain production, hybridomas previously screened for k production
bromide. and against l productionwere counted and plated at 106 per milliliter
Heterozygous 1/D mutants used in the heterozygote analyses in 24- or 96-well plates and grown for 48 hr, and supernatants were
were generated by RAG-deficient blastocyst complementation as harvested and quantitated as below. We analyzed 10 wild-type, 7
previously described (Chen et al., 1993c) using 39Ek1/D ES cells. N/N, and 15 D/D hybridomas. To analyze k and l production, serum
was collected from 5 to 9 mice of each genotype. All supernatants
were plated in duplicate wells in 1:3 serial dilutions from 1:3 toDNA and RNA Analysis
1:6561. Serum samples were plated in duplicate wells in 1:5 serialGenomic DNA was prepared as described previously (Laird et al.,
dilutions from 1:50 to 1:781,250. Concentrations were computed by1991). RNA was prepared using Trizol reagent (GIBCO BRL) as per
standard techniques. Absolute values were quantitated by con-the instructions of the manufacturer. Southern and Northern blot
structing a standard curve using known quantities of a k light chain–analyses were carried out as described elsewhere (Yancopoulos
containing antibody.et al., 1986), transferred to Zetaprobe membrane (Bio-Rad), and
hybridized with probes labeled by random hexamer priming with
[a-32P]dCTP. c-myc probe is a 420 bp PstI fragment within the c-myc Statistical Analysis
second exon. c-myb probe is a 650 bp XbaI–BglII genomic fragment For all statistical analyses, a one-way analysis of variance was per-
(Mucenski et al., 1991). RS probe is a 0.8 kb Sau3A fragment (Moore formed to determine the mean differences between groups. Follow-
et al., 1985). Densitometry was performed by first scanning with a ing each significant F test, multiple t tests were performed between
Molecular Dynamics PhosphorImager and then quantitating the sig- the 1/1 group and each mutant strain group. Bonferroni-corrected
nal by standard methods using the ImaqeQuant software program. P values less than 0.05 were considered significant. Data analysis
Background was defined as the average signal of the object border. and calculations were performed using the SPSS software package,
Objects were drawn to minimize contact with areas of signal. Total version 6.1 (SPSS Inc.). Error ranges presented in Tables 1 and 2
signal was calculated by volume integration. represent standard deviations.
AcknowledgmentsFlow Cytometry and Cell Sorting
Single cell suspensions were prepared from spleen, bone marrow,
thymus, and peripheral blood as described previously (Chen et al., Correspondence should be addressed to F. W. A. We thank Valerie
Stewart and Roger Ferrini for expert technical assistance; David1993b). Prepared cells were stained with fluorescein isothiocyanate
(FITC)-, phycoerythrin (PE)-, biotin-, or Cychrome-C (CyC)-conju- Zurakowski for expert assistance with the statistical analyses; Brian
Sauer and DuPont for the gift of pRH43 and pBS185 plasmids;gated antibodies and were analyzed by a FACScan (Becton–
Dickinson). Biotin conjugates were revealed by streptavidin CyC Michael Reth for the gift of plasmids pRx2-7, pRx-RI, and pRx-B6;
and Michael Mucenski for the c-myb probe. Ganciclovir was a gift(Pharmingen). The following Pharmingen rat anti-mouse monoclonal
antibodies were used in these studies: PE- or FITC-conjugated of Syntex Corporation, and E14.1 ES cells were a gift of Richard
Murray. EIIa–cre mice were a gift of M. Lakso, J. Pichels, and H.anti–k chain (R8-140); FITC- or biotin-conjugated anti-IgM (R6-60.2
or II-41); FITC-, PE-, biotin-, or CyC-conjugated anti-CD45R/B220 Westphal, with permission of DuPont. This work was supported by
39k Enhancer-Deleted Mice
251
the Howard Hughes Medical Institute and by National Institutes of Emorine, L., Kuehl, M., Weir, L., Leder, P., and Max, E. (1983). A
conserved sequence in the immunoglobulin Jk-Ck intron: possibleHealth grant A.I.20047. N. v. d. S. is supported by European Molecu-
lar Biology Organization fellowship ALTF-300-1995, and J. R. G. is enhancer element. Nature 304, 447–449.
supported in part by a fellowship from the Life and Health Insurance Ferradini, L., Gu, H., De Smet, A., Rajewsky, K., Reynaud, C.-A., and
Medical Research Fund. We thank Dennis Willerford and Barry Weill, J.-C. (1996). Rearrangement-enhancing element upstream of
Sleckman for critically reading this manuscript. the mouse immunoglobulin k chain J cluster. Science 271, 1416–
1420.
Received June 3, 1996; revised July 23, 1996. Fiering, S., Kim, C.G., Epner, E.M., and Groudine, M. (1993). An “in-
out” strategy using gene targeting and FLP recombinase for the
References functional dissection of complex DNA regulatory elements: analysis
of the b-globin locus control region. Proc. Natl. Acad. Sci. USA 90,
Abremski, K., Hoess, R., and Sternberg, N. (1983). Studies on the 8469–8473.
properties of P1 site-specific recombination: evidence for topologi-
Fiering, S., Epner, E., Robinson, K., Zhuang, Y., Telling, A., Hu, M.,cally unlinked products following recombination. Cell 32, 1301–1311.
Martin, D.I.K., Enver, T., Ley, T.J., and Groudine, M. (1995). Targeted
Alt,F.W., Enea, V.,Bothwell, A.L.M., and Baltimore, D. (1980). Activity deletion of 59HS2 of the murine b-globin LCR reveals that it is not
of multiple light chain genes in murine myeloma lines expressing a essential for proper regulation of the b-globin locus. Genes Dev. 9,
single, functional light chain. Cell 21, 1–12. 2203–2213.
Betz, A.G., Milstein, C., Gonzalez-Fernandez, A., Pannell, R., Larson, Forster, I., Vieira, P., and Rajewsky, K. (1989). Flow cytometric analy-
T., and Neuberger, M.S. (1994). Elements regulating somatic muta- sis of cell proliferation dynamics in the B cell compartment of the
tion: critical role for the intron enhancer/matrix attachment region. mouse. Int. Immunol. 1, 321–331.
Cell 77, 239–248.
Fulton, R., and Van Ness, B. (1993). k immunoglobulin promoters and
Blasquez, V.C., Xu, M., Moses, S.C., and Garrard, W.T. (1989). Immu- enhancers display developmentally controlled interactions. Nucl.
noglobulin k gene expression after stable integration. I. Role of the Acids Res. 21, 4941–4947.
intronic MAR and enhancer in plasmacytoma cells. J. Biol. Chem.
Fulton, R., and Van Ness, B. (1994). Selective synergy of immuno-264, 21183–21189.
globulin enhancer elements in B-cell development: a characteristic
Blasquez, V.C., Hale, M.A., Trevorrow, K.W., and Garrard, W.T. of k light chain enhancers, but not heavy chain enhancers. Nucl.
(1992). Immunoglobulin k gene enhancers synergistically activate Acids Res. 22, 4216–4223.
gene expression but independently determine chromatin structure.
Gu, H., Zou, Y.-R., and Rajewsky, K. (1993). Independent control ofJ. Biol. Chem. 267, 23888–23893.
immunoglobulin switch recombination at individual switch regions
Bories, J.-C., Demengeot, J., Davidson, L., and Alt, F.W. (1996). A
evidenced through Cre–loxP-mediated gene targeting. Cell 73,
critical role for transcriptional enhancer elements in controlling
1155–1164.
TCR-b accessibility. Proc. Natl. Acad. Sci. USA, in press.
Hiramatsu, R., Akagi, K., Matsuoka, H., Sakumi, K., Nakamura, H.,Bouvier, G., Watrin, F., Naspetti, M., Verthuy, C., Naquet, P., and
Kingsbury, L., David, C., Hardy, R.R., Yamamura, K., and Sakano,Ferrier, P. (1996). Deletion of the mouse T-cell receptor b gene
H. (1995). The 39 enhancer region determines the B/T specificity andenhancer blocks ab T-cell development. Proc. Natl. Acad. Sci. USA,
Pro-B/Pre-B specificity of immunoglobulin Vk–Jk joining. Cell 83,in press.
1113–1123.
Burstein, H.J., Tepper, R.I., Leder, P., and Abbas, A.K. (1991). Hu-
Kearney, J.F., Radbruch, A., Liesegang, B., and Rajewsky, K. (1979).moral immune functions in IL-4 transgenic mice. J. Immunol. 147,
A new mouse myeloma cell line that has lost immunoglobulin expres-2950–2956.
sion but permits the construction of antibody-secreting hybrid cell
Calame, K.L. (1985). Mechanisms that regulate immunoglobulin lines. J. Immunol. 123, 1548–1550.
gene expression. Annu. Rev. Immunol. 3, 159–195.
Kim, C.G., Epner, E.M., Forrester, W.C., and Groudine, M. (1992).
Calame, K., and Ghosh, S. (1995). Regulation of immunoglobulin Inactivation of the human b-globin gene by targeted insertion into
gene transcription. In Immunoglobulin Genes, Second Edition, T. the b-globin locus control region. Genes Dev. 6, 928–938.
Honjo and F.W. Alt, eds. (London: Academic Press), pp. 397–422.
Kogan, S.C., Doherty, M., and Gitschier, J. (1987). An improved
Carmack, C.E., Camper, S.A., Mackle, J.J., Gerhard, W.U., and Wei- method for prenatal diagnosis of genetic diseases by analysis of
gert, M.G. (1991). Influence of a Vk8 chain transgene on endogenous amplified DNA sequences: application to hemophilia A. New Engl.
rearrangements and the immune response to the HA(SB) determi- J. Med. 317, 985–990.
nant on influenza virus. J. Immunol. 147, 2024–2033.
Korsmeyer, S.J., Hieter, P.A., Sharrow, S.O., Goldman, C.K., Leder,
Chen, J., Young, F., Bottaro, A., Stewart, V., Smith, R.K., and Alt,
P., and Waldmann, T.A. (1982). Normal human B cells display or-
F.W. (1993a). Mutations of the intronic IgH enhancer and its flanking
dered light chain gene rearrangement and deletions. J. Exp. Med.
sequences differentially affect accessibility of the JH locus. EMBO
156, 975–985.
J. 12, 4635–4645.
Kuhn, R., Rajewsky, K., and Muller, W. (1991). Generation and analy-
Chen, J., Trounstine, M., Kurahara, C., Young, F., Kuo, C.-C., Xu,
sis of interleukin-4 deficient mice. Science 254, 707–710.
Y., Loring, J.F., Alt, F.W., and Huszar, D. (1993b). B cell development
Laird, P.W., Zijderveld, A., Linders, K., Rudnicki, M.A., Jaenisch, R.,in mice that lack one or both immunoglobulin k light chain genes.
and Berns, A. (1991). Simplified mammalian DNA isolation proce-EMBO J. 12, 821–830.
dure. Nucl. Acids Res. 19, 4293.Chen, J., Lansford, R., Stewart, V., Young, F., and Alt, F.W. (1993c).
Lakso, M., Pichel, J.G., Gorman, J.R., Sauer, B., Okamoto, Y., Lee,RAG-2-deficient blastocyst complementation: an assay of gene
E., Alt, F.W., and Westphal, H. (1996). Efficient in vivo excision offunction in lymphocyte development. Proc. Natl. Acad. Sci. USA 90,
genomic sequences at the zygote stage of mouse development.4528–4532.
Proc. Natl. Acad. Sci. USA 93, 5860–5865.Chen, J., Shinkai, Y., Young, F., and Alt, F.W. (1994). Probing immune
Langman, R.E., and Cohn, M. (1995). The proportion of B-cell sub-functions in RAG-deficient mice. Curr. Biol. 6, 313–319.
sets expressing k and l light chains changes following antigenicCogne, M., Lansford, R., Bottaro, A., Zhang, J., Gorman, J., Young,
selection. Immunol. Today 16, 141–144.F., Cheng, H.L., and Alt, F.W. (1994). A class switch control region
Lansford, R., Okada, A., Chen, J., Oltz, E.M., Blackwell, T.K., Alt,at the 39 end of the immunoglobulin heavy chain locus. Cell 77,
F.W., and Rathbun, G. (1996). Mechanism and control of immuno-737–747.
globulin gene rearrangement. In Molecular Immunology, B.D. HamesColeclough, C., Perry, R.P., Karjalainen, K., and Weigert, M. (1981).
and D.M. Glover, eds. (New York: IRL Press), pp. 1–100.Aberrant rearrangements contribute significantly to the allelic exclu-
sion of immunoglobulin gene expression. Nature 290, 372–378. Lenardo, M., Pierce, J.W., and Baltimore, D. (1987). Protein-binding
Immunity
252
sites in Ig gene enhancers determine transcriptional activity and Storb, U., O’Brien, R.L., McMullen, M.D., Gollahon, K.A., and Brin-
ster, R.L. (1984). High expression of cloned immunoglobulin k geneinducibility. Science 236, 1573–1577.
in transgenic mice is restricted to B lymphocytes. Nature 310,Mansour, S.L., Thomas, K.R., and Capecchi, M.R. (1988). Disruption
238–241.of the proto-oncogene int-2 in mouse embryo-derived stem cells:
Storb, U., Engler, P., Klotz, E., Weng, A., Haasch, D., Pinkert, C.,a general strategy for targeting mutations to non-selectable genes.
Doglio, L., Glymore, M., and Brinster, R. (1992). Rearrangement andNature 336, 348–352.
expression of immunoglobulin genes in transgenic mice. Curr. Top.Meyer, K.B., and Neuberger, M.S. (1989). The immunoglobulin k
Microbiol. Immunol. 182, 137–141.locus contains a second, stronger B-cell-specific enhancer which is
Takeda, S., Zou, Y.-R., Bluethmann, H., Kitamura, D., Muller, U., andlocated downstream of the constant region. EMBO J. 8, 1959–1964.
Rajewsky, K. (1993). Deletion of the immunoglobulin k chain intron
Meyer, K.B., Sharpe, M.J., Surani, M.A., and Neuberger, M.S. (1990).
enhancer abolishes k chain gene rearrangement in cis but not l
The importance of the 39-enhancer region in immunoglobulin k gene
chain gene rearrangement in trans. EMBO J. 12, 2329–2336.
expression. Nucl. Acids Res. 18, 5609–5615.
Tybulewicz, V.L., Crawford, C.E., Jackson, P.K., Bronson, R.T., and
Moore, M.W., Durdik, J., Persiani, D.M., and Selsing, E. (1985). Dele- Mulligan, R.C. (1991). Neonatal lethality and lymphopenia in mice
tions of k chain constant region genes in mouse l-chain producing with a homozygous disruption of the c-abl proto-oncogene. Cell 65,
B cells involve intrachromosomal DNA recombinations similar to 1153–1163.
V-J joining. Proc. Natl. Acad. Sci. USA 82, 6211–6215.
Van Ness, B.G., Weigert, M., Colecough, C., Mather, E.L., Kelley,
Mucenski, M.L., McLain, K., Kier, A.B., Swerdlow, S.H., Schreiner, D.E., and Perry, R.P. (1981). Transcription of the unrearranged
C.M., Miller, T.A., Pietryga, D.W., Scott, W.J.J., and Potter, S.S. mouse Ck locus: sequence of the initiation region and comparison
(1991). A functional c-myb gene is required for normal murine fetal of activity with a rearranged Vk–Ck gene. Cell 27, 593–600.
hepatic hematopoiesis. Cell 65, 677–689.
Xu, Y., Davidson, L., Alt, F.W., and Baltimore, D. (1996). Deletion of
Muller, B., Stappert, H., and Reth, M. (1990). A physical map and the Igk light chain intron enhancer/matrix attachment region impairs
analysis of the murine Ck-RS region show the presence of a con- but does not abolish VkJk rearrangement. Immunity 4, 377–385.
served element. Eur. J. Immunol. 20, 1409–1411. Yancopoulos, G.D., Blackwell, T.K., Suh, H., Hood, L., and Alt, F.W.
Nadel, B., Cazenave, P.-A., and Sanchez, P. (1990). Murine l re- (1986). Introduced T cell receptor variable region gene segments
arrangements: the stochastic model prevails over the ordered recombine in pre-B cells: evidence that B and T cells use a common
model. EMBO J. 9, 435–440. recombinase. Cell 44, 251–259.
Okada, A., and Alt, F.W. (1995). The variable region gene assembly Zou, Y.-R., Takeda,S., and Rajewsky, K. (1993). Gene targeting in the
mechanism. In Immunoglobulin Genes, Second Edition, T. Honjo Igk locus: efficient generation of l expressing B cells independent of
and F.W. Alt, eds. (London: Academic Press), pp. 205–234. gene rearrangement in Igk. EMBO J. 12, 811–820.
Park, K., and Atchison, M.L. (1991). Isolation of a candidate repres-
sor/activator, NF-E1 (YY-1, d), that binds to the immunoglobulin k
39 enhancer and the immunoglobulin heavy-chain muE1 site. Proc.
Natl. Acad. Sci. USA 88, 9804–9808.
Parslow, T.G., and Granner, D.K. (1982). Chromatin changes accom-
pany immunoglobulin k gene activation. Nature 229, 449–451.
Picard, D., and Schaffner, W. (1984). A lymphocyte-specific en-
hancer in the mouse immunoglobulin k gene. Nature 307, 80–82.
Pongubala, J.M.R., and Atchison, M.L. (1991). Functional character-
ization of the developmentally controlled immunoglobulin k 39 en-
hancer: regulation by Id, a repressor of helix-loop-helix transcription
factors. Mol. Cell. Biol. 11, 1040–1047.
Pongubala, J.M.R., Nagulapalli, S., Klemsz, M.J., McKercher, S.R.,
Maki, R.A., and Atchison, M.L. (1992). PU.1 Recruits a second nu-
clear factor to a site important for immunoglobulin k 39 enhancer
activity. Mol. Cell. Biol. 12, 368–378.
Ritchie, K.A., Brinster, R.L., and Storb, U. (1984). Allelic exclusion
and control of endogenous immunoglobulin gene rearrangement in
k transgenic mice. Nature 312, 517–520.
Rusconi, S., and Kohler, G. (1985). Transmission and expression of
a specific pair or rearranged immunoglobulin m and k genes in a
transgenic mouse line. Nature 314, 330–334.
Schlissel, M.S., and Baltimore, D. (1989). Activation of immunoglob-
ulin k gene rearrangement correlates with induction of germline k
gene transcription. Cell 58, 1001–1007.
Selsing, E., and Daitch, L.E. (1995). Immunoglobulin l genes. In
Immunoglobulin Genes, Second Edition, T. Honjo and F.W. Alt, eds.
(London: Academic Press), pp. 193–203.
Serwe, M., and Sablitzky, F. (1993). V(D)J recombination in B cells is
impaired but not blocked by targeted deletion of the immunoglobulin
heavy chain intron enhancer. EMBO J. 12, 2321–2327.
Shinkai, Y., Rathbun, G., Lam, K.P., Oltz, E.M., Stewart, V., Mendel-
sohn, M., Charron, J., Datta, M., Young, F., Stall, A.M., et al. (1992).
RAG-2-deficient mice lack mature lymphocytes owing to inability to
initiate V(D)J rearrangement. Cell 68, 855–867.
Sleckman, B.P., Gorman, J.R., and Alt, F.W. (1996). Accessibility
control of antigen-receptor variable-region gene assembly: role of
cis-acting elements. Annu. Rev. Immunol. 14, 459–481.
